-
-
Anti-Amyloid Beta Reference Antibody (lecanemab),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (Merck anti-Amyloid beta 19.3),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (Kumamoto U. patent anti-Amyloid Beta),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (Georgetown U. patent anti-Amyloid Beta),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (GSK 933776),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (gantenerumab),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (DLX212),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (donanemab),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (CSIRO anti-amyloid Beta scFv),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (CNTO 2125),, 50 микрограмм
-
Anti-Amyloid Beta Reference Antibody (crenezumab),, 50 микрограмм
стр.: